Literature DB >> 27008883

Swiftly Decreasing Cerebrospinal Fluid Cathelicidin Concentration Predicts Improved Outcome in Childhood Bacterial Meningitis.

Okko Savonius1,2, Otto Helve3,2, Irmeli Roine4, Sture Andersson3,2, Josefina Fernández5, Heikki Peltola3,2, Tuula Pelkonen3,2.   

Abstract

We investigated cerebrospinal fluid (CSF) cathelicidin concentrations in childhood bacterial meningitis on admission and during antimicrobial treatment. CSF cathelicidin concentrations on admission correlated with CSF white cell counts and protein levels but not with bacterial etiology. A greater decrease in the concentration in response to treatment was associated with a better outcome. Since the CSF cathelicidin concentration reflects the degree of central nervous system (CNS) inflammation, it may be used as a novel biomarker in childhood bacterial meningitis. An early decrease during treatment likely signals more rapid mitigation of the disease process and thus a better outcome.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27008883      PMCID: PMC4879275          DOI: 10.1128/JCM.00420-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Influence of admission findings on death and neurological outcome from childhood bacterial meningitis.

Authors:  Irmeli Roine; Heikki Peltola; Josefina Fernández; Inés Zavala; Antonio González Mata; Silvia González Ayala; Antonio Arbo; Rosa Bologna; Greta Miño; José Goyo; Eduardo López; Solange Dourado de Andrade; Seppo Sarna
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

Review 2.  A comprehensive summary of LL-37, the factotum human cathelicidin peptide.

Authors:  Dieter Vandamme; Bart Landuyt; Walter Luyten; Liliane Schoofs
Journal:  Cell Immunol       Date:  2012-11-29       Impact factor: 4.868

3.  Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis.

Authors:  M M Mustafa; M H Lebel; O Ramilo; K D Olsen; J S Reisch; B Beutler; G H McCracken
Journal:  J Pediatr       Date:  1989-08       Impact factor: 4.406

4.  Intrathecal application of the antimicrobial peptide CRAMP reduced mortality and neuroinflammation in an experimental model of pneumococcal meningitis.

Authors:  Arndt Dörr; Eugenia Kress; Rainer Podschun; Thomas Pufe; Simone C Tauber; Lars-Ove Brandenburg
Journal:  J Infect       Date:  2015-04-17       Impact factor: 6.072

5.  Assessment of outcome after severe brain damage.

Authors:  B Jennett; M Bond
Journal:  Lancet       Date:  1975-03-01       Impact factor: 79.321

6.  Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptide in meningitis.

Authors:  Lars-Ove Brandenburg; Deike Varoga; Nicoletta Nicolaeva; Stephen L Leib; Henrik Wilms; Rainer Podschun; Christoph J Wruck; Jens-Michael Schröder; Thomas Pufe; Ralph Lucius
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

7.  Role of the cathelicidin-related antimicrobial peptide in inflammation and mortality in a mouse model of bacterial meningitis.

Authors:  Julika Merres; Jonas Höss; Lea-Jessica Albrecht; Eugenia Kress; Oliver Soehnlein; Sandra Jansen; Thomas Pufe; Simone C Tauber; Lars-Ove Brandenburg
Journal:  J Innate Immun       Date:  2013-08-22       Impact factor: 7.349

8.  Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial.

Authors:  Heikki Peltola; Irmeli Roine; Josefina Fernández; Inés Zavala; Silvia González Ayala; Antonio González Mata; Antonio Arbo; Rosa Bologna; Greta Miño; José Goyo; Eduardo López; Solange Dourado de Andrade; Seppo Sarna
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

9.  Host immune response to tuberculous meningitis.

Authors:  Douwe H Visser; Regan S Solomons; Katharina Ronacher; Gijs T van Well; Martijn W Heymans; Gerhard Walzl; Novel N Chegou; Johan F Schoeman; Anne M van Furth
Journal:  Clin Infect Dis       Date:  2014-10-09       Impact factor: 9.079

10.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

Authors:  Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2012-05-11       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.